Corbett; Jeffrey W.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Corbett; Jeffrey W..The latest application filed is for "substituted indazole amides and their use as glucokinase activators".

Company Profile

1.10.24

Corbett; Jeffrey W. - Niantic CT
Corbett; Jeffrey W. - Portage MI
Corbett, Jeffrey W. - Niatic CT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pyrazolospiroketone acetyl-CoA carboxylase inhibitors Grant 8,318,762 - Corbett , et al. November 27, 2	2012-11-27
Substituted Indazole Amides And Their Use As Glucokinase Activators App 20110319379 - Corbett; Jeffrey W. ; et al.	2011-12-29
Pyrazolospiroketone Acetyl-CoA Carboxylase Inhibitors App 20110028390 - Corbett; Jeffrey W. ; et al.	2011-02-03
Compounds as CRF.sub.1 receptor antagonists Grant 7,250,418 - Corbett , et al. July 31, 2	2007-07-31
Substituted pyrimidine derivatives Grant 7,087,617 - Corbett , et al. August 8, 2	2006-08-08
Substituted aryl 1, 4-pyrazine derivatives Grant 7,041,672 - Verhoest , et al. May 9, 2	2006-05-09
Substituted pyrimidinones and pyrimidinthiones Grant 7,015,229 - Fu , et al. March 21, 2	2006-03-21
Substituted aryl 1,4-pyrazine derivatives Grant 6,992,087 - Verhoest , et al. January 31, 2	2006-01-31
Substituted pyrazine derivatives Grant 6,964,965 - Corbett , et al. November 15, 2	2005-11-15
Positive allosteric modulators of the nicotinic acetylcholine receptor App 20050250816 - Piotrowski, David W. ; et al.	2005-11-10
Treatment of diseases with combinations of alpha 7 Nicotinic Acetylcholine Receptor agonists and other compounds App 20050245504 - Corbett, Jeffrey W. ; et al.	2005-11-03
Substituted pyrimidine derivatives App 20050101613 - Corbett, Jeffrey W. ; et al.	2005-05-12
Substituted aryl 1, 4-pyrazine derivatives App 20050049257 - Verhoest, Patrick R. ; et al.	2005-03-03
Compounds as CRF1 receptor antagonists App 20050038040 - Corbett, Jeffrey W. ; et al.	2005-02-17
N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease Grant 6,849,620 - Walker , et al. February 1, 2	2005-02-01
Positive allosteric modulators of the nicotinic acetylcholine receptor App 20040254373 - Piotrowski, David W. ; et al.	2004-12-16
Positive allosteric modulators of the nicotinic acetylcholine receptor App 20040249150 - Piotrowski, David W. ; et al.	2004-12-09
Quinuclidine-substituted hetero-bicyclic aromatic compounds for the treatment of disease App 20040224977 - Walker, Daniel Patrick ; et al.	2004-11-11
Substituted 1,4-pyrazine derivatives App 20040116444 - Corbett, Jeffrey W. ; et al.	2004-06-17
Substituted pyrazine derivatives App 20040053941 - Corbett, Jeffrey W. ; et al.	2004-03-18
Positive allosteric modulators of the nicotinic acetylcholine receptor App 20030236287 - Piotrowski, David W. ; et al.	2003-12-25
Substituted pyrimidinones and pyrimidinthiones App 20030195222 - Fu, Jian-Min ; et al.	2003-10-16
N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease App 20030176702 - Walker, Daniel Patrick ; et al.	2003-09-18
Novel N-acylated heterocycles App 20030162777 - Leonardi, Amedeo ; et al.	2003-08-28
Substituted aryl 1,4-pyrazine derivatives App 20030144297 - Verhoest, Patrick R. ; et al.	2003-07-31
Quinuclidine-substituted heteroaryl moieties for treatment of disease Grant 6,599,916 - Myers , et al. July 29, 2	2003-07-29
Substituted 7-aza[2.2.1]bicycloheptanes for the treatment of disease App 20030105089 - Wishka, Donn G. ; et al.	2003-06-05
4,4-disubstituted-3,4-dihydro-2(1H)-quinazolines useful as HIV reverse transcriptase inhibitors App 20030092722 - Corbett, Jeffrey W. ; et al.	2003-05-15
Quinuclidine-substituted hetero-bicyclic aromatic compounds for the treatment of disease App 20030073707 - Walker, Daniel Patrick ; et al.	2003-04-17
Substituted-heteroaryl-7-aza[2.2.1] Bycycloheptanes For The Treatment Of Desease App 20030069290 - Wishka, Donn G. ; et al.	2003-04-10
Quinuclidine-substituted heteroaryl moieties for treatment of disease Grant 6,500,840 - Myers , et al. December 31, 2	2002-12-31
Quinuclidine-substituted heteroaryl moieties for treatment of disease App 20020091135 - Myers, Jason K. ; et al.	2002-07-11
Quinuclidine-substituted heteroaryl moieties for treatment of disease App 20020042428 - Myers, Jason K. ; et al.	2002-04-11
Quinuclidine-substituted heteroaryl moieties for treatment of disease App 20020042429 - Myers, Jason K. ; et al.	2002-04-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.